Table IV.
Analysis of variables associated with the presence of cirrhosis in patients with chronic hepatitis B.
| Variable | Univariate analysis
|
Multivariate analysis
|
||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | |
| Clinical data | ||||||
| Male (%) | 1.267 | 0.468–3.433 | 0.642 | |||
| Age (years) | 1.042 | 0.981–1.108 | 0.181 | |||
| BMI (kg/m2) | 1.143 | 0.981–1.331 | 0.086 | |||
| Biological parameters | ||||||
| AST (U/l) | 1.001 | 0.991–1.011 | 0.901 | |||
| ALT (U/l) | 1.001 | 0.996–1.006 | 0.590 | |||
| GGT (U/l) | 1.014 | 1.002–1.026 | 0.018 | 1.012 | 1.000–1.024 | 0.049 |
| Serum albumin (g/l) | 0.849 | 0.744–0.969 | 0.015 | 1.306 | 0.986–1.729 | 0.063 |
| Total bilirubin (µmol/l) | 1.024 | 0.975–1.076 | 0.341 | |||
| WBC (×1,000/mm3) | 0.898 | 0.656–1.229 | 0.502 | |||
| Platelet count (×1,000/mm3) | 0.982 | 0.970–0.993 | 0.002 | 0.989 | 0.966–1.012 | 0.343 |
| Fasting glucose (mmol/l) | 1.064 | 0.767–1.475 | 0.710 | |||
| HBV-DNA (log10 IU/l) | 0.987 | 0.768–1.268 | 0.916 | |||
| HBeAg positive (%) | 0.842 | 0.322–2.198 | 0.725 | |||
| Ultrasonographic parameters | ||||||
| Portal vein diameter (mm) | 1.418 | 1.010–1.992 | 0.044 | 0.835 | 0.447–1.559 | 0.571 |
| Portal vein velocity (cm/s) | 0.954 | 0.883–1.030 | 0.226 | |||
| Hepatic artery diameter (mm) | 2.133 | 1.539–4.589 | 0.002 | 4.467 | 0.621–32.149 | 0.137 |
| Hepatic artery velocity (cm/s) | 1.007 | 0.986–1.028 | 0.543 | |||
| Hepatic artery resistive index | 0.008 | 0.001–6.408 | 0.158 | |||
| Spleen thickness (mm) | 1.102 | 1.002–1.213 | 0.045 | 0.977 | 0.720–1.328 | 0.884 |
| Spleen diameter (mm) | 1.101 | 1.032–1.176 | 0.004 | 1.155 | 0.969–1.377 | 0.107 |
| Splenic index | 1.188 | 1.094–1.290 | <0.001 | 1.100 | 0.937–1.292 | 0.245 |
| Splenoportal index | 6.513 | 2.583–16.422 | <0.001 | 5.676 | 1.939–16.618 | 0.002 |
| Splenic artery diameter (mm) | 2.103 | 1.141–3.874 | 0.017 | 0.483 | 0.068–3.437 | 0.468 |
| Splenic artery velocity (cm/s) | 1.003 | 0.981–1.025 | 0.820 | |||
| Splenic artery resistive index | 0.950 | 0.699–1.291 | 0.744 | |||
| Splenic vein diameter (mm) | 1.890 | 1.199–2.980 | 0.006 | 2.729 | 0.701–10.622 | 0.148 |
| Splenic vein velocity (cm/s) | 0.896 | 0.809–0.992 | 0.034 | 1.039 | 0.974–1.323 | 0.103 |
| APRI | 1.011 | 0.995–1.029 | 0.186 | |||
| FIB-4 | 2.082 | 1.254–3.456 | 0.005 | |||
| Liver stiffness (FibroScan kPa) | 1.492 | 1.247–1.785 | <0.001 | |||
| LFI | 13.944 | 3.603–53.960 | <0.001 | 14.102 | 2.873–69.221 | 0.001 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; APRI, aspartate aminotransferase to platelet ratio index; BMI, body mass index; FIB-4, fibrosis-4 index; GGT, γ-glutamyl transferase; HBV, hepatitis B virus; LFI, liver-fibrosis index; WBC, white blood cell; HbeAg, hepatitis B virus envelope antigen.